The article provides an overview of the analyst ratings for Amedisys in the last 3 months. The average price target of $100.0 represents a 6.1% decrease from the previous average, which may indicate a slightly negative sentiment. However, the ratings are mixed with 4 bullish and 8 indifferent, suggesting a neutral short-term impact on the stock price.